University of Patras
Ενδο- και δια-ιστικά δίκτυα συνέκφρασης των μεταγραφικών παραγόντων ERb (Estrogen Receptor β) και NFATc1 (Nuclear Factor of Activated T cells) και ο ρόλος κλειδί του συμπαράγοντα TIF2 στην κλινικά σοβαρή παχυσαρκία: μια συστημική προσέγγιση της παχυσαρκίας και των συνοδών καρδιομεταβολικών νοσημάτων
Abstract
dc:descriptionEstrogen receptor β (ERβ) plays an important role in human metabolism and some of its metabolic actions are mediated by a positive “cross-talk” with Nuclear Factor of Activated T cells (NFAT) and the key metabolic transcriptional coregulator Transcriptional Intermediary Factor 2 (TIF2). Moreover, it has already been demonstrated that obesity is characterized by a chronic, low grade, systemic inflammation. However, little is known about the role of skeletal muscle, which represents an active metabolic organ whose activities need to be determined.Our study is an “in situ” morphological evaluation of the communication between ERβ, NFAT and TIF2 in morbid obesity. Furthermore, we want to detect the relationships between skeletal muscle and adipose tissue inflammation with nonalcoholic fatty liver disease (NAFLD) and diabetes, as well as to explore associations with clinicopathological parameters.Methods: Our population consists of 50 morbidly obese patients undergoing planned bariatric surgery, during which biopsies were taken from visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), skeletal muscle (SM), extramyocellular adipose tissue (EMAT) and liver. The differential protein expression of ERβ, NFATc1, TIF2, CD3, CD68, was evaluated by immunohistochemistry.Results: We demonstrated an extensive intra- and inter-tissue co-expression network, which confirms the tissue-specific and integral role of each one of the investigated proteins in morbid obesity. Moreover, a beneficial role of ERβ and NFATc1 against NAFLD is implicated, whereas the distinct roles of TIF2 still remain an enigma. A novel finding is the intricate cross-talk between SM, EMAT and the liver and the possible correlation between SM, EMAT inflammation and the presence of liver fibrosis.Conclusions: In summary, obesity should not be regarded as a “lone” entity but as part of a complex, highly interlinked disease network. In this context we should base our thinking and research in order to identify the common genetic origins and address the key biomarkers that need to be targeted so as to provide novel and efficient treatments. Our findings support the “disease network theory”, as we detected a complicated inter- and intra-tissue co-expression network that links obesity-induced inflammation in the investigated tissues with non-alcoholic fatty liver disease. Specifically, inflammatory biomarkers (CD68, CD3) in all adipose depots were found to be positively correlated with serum liver transaminases and the presence of NASH, whereas CD3 expression in skeletal muscle and EMAT is linked to liver fibrosis as assessed by biopsy.Moreover, ERβ, NFATc1 and TIF2 were identified as highly differentially co-expressed biomarkers across tissues, showing their potential role in obesity-induced disease such as type II diabetes and NAFLD. Specifically, our findings imply a beneficial role of ERβ and NFATc1 against NAFLD and a more equivocal role of TIF2 in the pathogenesis of diabetes and liver fibrosis. We also showed that these biomarkers were consistently clustering together within tissues in similar co-expression patterns and subnetworks, such as between SAT and VAT or between SM and EMAT. Moreover, the co-expressed biomarkers were found to be associated with plasma lipid and transaminases’ levels, which underlines their significance in lipid and glucose metabolism. Co-expression network analysis represents a new approach for systems-level analysis, which may facilitate the development of new diagnostics and therapeutics by targeting the interactions in several chronic diseases. Our results could be applied to understand the systemic details of obesity and its comorbidities, in the context of inter-organ interactions. For example, adipose or skeletal muscle biopsy, along with liver transaminases’ levels and novel imaging techniques, can accurately detect subtle hepatic disease and may substitute for liver biopsy in the near future. There is no doubt that further research is needed in order to advance our understanding of the molecular mechanisms that contribute to liver steatosis, NASH, and fibrosis in obese subjects and identify novel and promising therapeutic targets.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chasapi, Athina
- Χασάπη, Αθηνά
Subjects
dc:subject × 52- Παχυσαρκία
- Σακχαρώδης διαβήτης
- Καρδιομεταβολικά νοσήματα
- Μεταγραφικοί παράγοντες
- ERβ
- NFATc1
- Συμπαράγοντες της μεταγραφής
- TIF2/SRC2
- Ιατρική των δικτύων
- Λειτουργική Διαντίδραση
- Ενδο- και δια-ιστικά δίκτυα συνέκφρασης
- Μεταβολικό σύνδρομο
- Βιοδείκτες
- Συστημική προσέγγιση
- Φλεγμονή
- Λιπώδης ιστός
- Ήπαρ
- Σκελετικός μυς
- Μη αλκοολική λιπώδης νόσος του ήπατος
- Μη αλκοολική στεατοηπατίτιδα
- Ηπατική ίνωση
- Ανοσοϊστοχημεία
- CD3
- CD68
- Βαριατρικό χειρουργείο
- Βιοψία
- Μορφολογική εκτίμηση
- Obesity
- Diabetes mellitus
- Cardiometabolic diseases
- Transcription factors
- Coregulators of transcription
- Network Medicine
- Intra- and Inter-tissue co-expression networks
- Metabolic syndrome
- Biomarkers
- Systemic approach
- Inflammation
- Adipose tissue
- Liver
- Skeletal muscle
- Non alcoholic fatty liver disease (NAFLD)
- Non alcoholic steatohepatitis (NASH)
- Liver fibrosis
- Immunohistochemistry (IHC)
- Bariatric surgery
- Biopsy
- Morphological evaluation
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45818